相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates
W. Gonsiorek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Pivotal Advance:: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
Mohanraj Rajesh et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Vascular adhesion molecules in atherosclerosis
Elena Galkina et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Mohanraj Rajesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Pharmacological inhibition of CB1 cannabinoid raceptor protects against doxorubicin-induced cardiotoxicity
Partha Mukhopadhyay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase
Sandor Batkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Attenuation of allergic contact dermatitis through the endocannabinoid system
Meliha Karsak et al.
SCIENCE (2007)
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sandor Batkai et al.
FASEB JOURNAL (2007)
Macrophages and their products in rheumatoid arthritis
Zoltan Szekanecz et al.
CURRENT OPINION IN RHEUMATOLOGY (2007)
Temporal variation in CB2R levels following T lymphocyte activation:: Evidence that cannabinoids modulate CXCL12-induced chemotaxis
Karen Coopman et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: Potential role for CB2-selective ligands as immunosuppressive agents
Catherine Lombard et al.
CLINICAL IMMUNOLOGY (2007)
Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling
Joseph Tam et al.
MOLECULAR PHARMACOLOGY (2006)
The immune response in atherosclerosis: a double-edged sword
Goran K. Hansson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes
Sharmistha Ghosh et al.
MOLECULAR IMMUNOLOGY (2006)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Fatima Teixeira-Clerc et al.
NATURE MEDICINE (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo
CA Lunn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Peripheral cannabinoid receptor, CB2, regulates bone mass
O Ofek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Leukocyte recruitment in atherosclerosis: Potential targets for therapeutic approaches?
V. Braunersreuther et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cannabinoid receptor type 2 gene is associated with human osteoporosis
M Karsak et al.
HUMAN MOLECULAR GENETICS (2005)
MCP-1-stimulated chemotaxis of monocytic and endothelial cells is dependent on activation of different signaling cascades
TI Arefieva et al.
CYTOKINE (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
S Steffens et al.
NATURE (2005)
Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation
M Jaksch et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro
P Sacerdote et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor:: Biochemical and pharmacological characterization
M Rinaldi-Carmona et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Chemokines - Key regulators of mononuclear cell recruitment in atherosclerotic vascular disease
C Weber et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model
X Ni et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
The cannabinoid system and immune modulation
TW Klein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
A Klegeris et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies
IS Lossos et al.
LEUKEMIA (2003)
Human leptin promotes survival of human circulating blood monocytes prone to apoptosis by activation of p42/44 MAPK pathway
S Najib et al.
CELLULAR IMMUNOLOGY (2002)
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
RJ McKallip et al.
BLOOD (2002)
Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1,-2,-3 and-4
JH Wain et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: Increase in endogenous cannabinoids in the sera of patients with endotoxic shock
Y Wang et al.
ANALYTICAL BIOCHEMISTRY (2001)
Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis
S Bátkai et al.
NATURE MEDICINE (2001)
Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis
N Ashida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Evaluation of signal transduction pathways in chemoattractant-induced human monocyte chemotaxis
JS Fine et al.
INFLAMMATION (2001)
Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and TH1-like/CD45RO+ T cells
C Weber et al.
BLOOD (2001)
Signal transduction involved in MCP-1-mediated monocytic transendothelial migration
B Cambien et al.
BLOOD (2001)
In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors
P Sacerdote et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
分享论文
